Type 2 Diabetes, Explained Properly

Around five million people in the UK have diabetes, the large majority of it type 2, and a striking number of them have never had the condition properly explained. They've been given a diagnosis, a leaflet, a prescription, and a vague sense that they did something wrong involving sugar. What they often haven't been given is the actual story — which is a pity, because the actual story is more interesting, less blaming, and considerably more hopeful than the folk version.

So here it is, told properly.

Two problems, not one

Type 2 diabetes is usually described as "high blood sugar," which is true in the way that describing a fire as "high temperature" is true. The raised glucose is the consequence. Underneath it sit two distinct problems.

The first is insulin resistance. Insulin is the hormone that tells your muscles, liver and fat tissue to take glucose out of the blood and use or store it. In insulin resistance, those tissues stop listening properly. The signal is sent; the response is sluggish. The pancreas compensates by shouting louder — producing more insulin — and for years, often decades, this works. Blood glucose stays normal while insulin levels quietly climb. Nothing shows on a standard test. Nothing feels wrong.

The second problem is beta-cell decline. The beta cells of the pancreas are the insulin factories, and they cannot shout forever. Under sustained demand — and, the evidence increasingly suggests, under the burden of fat accumulating in and around the pancreas itself — their output begins to fall. When insulin production can no longer overcome insulin resistance, glucose rises, and at some point it crosses a diagnostic line.

That line is where most people's story begins. Biologically, it's closer to the middle. By the time type 2 diabetes is diagnosed, a substantial share of beta-cell function has typically already been lost, and the process has usually been running for years.

Why it develops — and why "you ate too much sugar" misses the point

The strongest risk factors are excess weight (particularly fat stored around the organs — visceral fat), genetics, age, ethnicity, and physical inactivity. Family history matters a great deal: type 2 diabetes is one of the more heritable common conditions, which is why it clusters in families who eat no differently from their neighbours. South Asian, Black African and Black Caribbean populations develop it at lower body weights and younger ages.

Sugar is not irrelevant — sugary drinks in particular are associated with risk, largely through their effect on weight — but the idea that sugar alone causes diabetes is wrong in both directions. People with high-sugar diets and resilient metabolism may never develop it; people with modest diets and the wrong genetics may. And thin people are not exempt. Some store fat in precisely the wrong places — liver and pancreas — at body weights that look unremarkable, a pattern sometimes summarised as a "personal fat threshold." A normal BMI is not a certificate of metabolic immunity.

None of this is about willpower or character. It's biology meeting an environment that biology never evolved for.

A progressive condition — with an asterisk

Traditionally, type 2 diabetes has been understood as progressive: beta-cell function continues to decline, treatment escalates over time, and the job of management is to slow the slope. That framing remains broadly accurate for many people, and it's why ongoing review matters rather than a one-off fix.

Management, as described in UK and international guidance, rests on several layers. Lifestyle measures — diet quality, physical activity, weight management — sit underneath everything, with genuine effect on glucose, blood pressure and cardiovascular risk. Metformin has long been the usual first medicine, with decades of safety data behind it. Newer classes — SGLT2 inhibitors and GLP-1 receptor agonists — have changed the field, not just by lowering glucose but by demonstrating protection of hearts and kidneys in large outcome trials, which is why guidelines now position them prominently for people with cardiovascular or kidney disease. Insulin remains an important tool when the pancreas can no longer keep up; needing it is a reflection of biology, not failure.

Which of these is right for a given person depends on their kidneys, their heart, their weight, their other medicines and their preferences — exactly the kind of decision that belongs in a consultation with a clinician who knows the whole picture, not in an article.

The remission story, told honestly

The asterisk on "progressive" arrived with the DiRECT trial. UK primary-care patients with relatively recent type 2 diabetes were supported through a structured, intensive weight-management programme. At one year, around 46% were in remission — non-diabetic glucose levels without glucose-lowering medication — and remission tracked closely with weight lost: among those losing 15 kg or more, the majority achieved it.

This was a genuinely important result. It showed that for some people, particularly earlier in the condition with significant weight to lose, type 2 diabetes is not a one-way street. The likely mechanism — draining fat from the liver and pancreas, allowing beta cells to recover function — fits the biology described above.

But honesty requires the rest of the data. Remission rates fell over time as weight returned: roughly a third of the original intervention group remained in remission at two years, and a smaller minority at five. Remission is also not the same as cure: glucose can rise again, the underlying susceptibility remains, and monitoring continues. The accurate summary is that remission is real, achievable for some, strongly linked to substantial weight loss, and requires maintenance — not a miracle, and not a moral test that people who don't achieve it have failed.

Practical takeaways

• Type 2 diabetes is two problems — insulin resistance plus declining insulin production — and it usually runs silently for years before diagnosis.
• It is driven by genetics, body fat distribution, age and environment, not by sugar alone, and not by weak character; thin people can develop it too.
• Modern management is layered — lifestyle, established medicines, and newer classes with proven heart and kidney benefits — and the right combination is an individual decision made with a clinician.
• Remission is genuinely possible for some people, especially early on with substantial weight loss (DiRECT), but it needs maintaining and is not a guaranteed cure.

What this doesn't mean

It doesn't mean everyone with type 2 diabetes can reverse it, or that anyone still taking medication has fallen short. Biology, duration of diabetes, and life circumstances differ enormously. Nor does it mean medication is a lesser path — for many people, medicines are precisely what protects their heart, kidneys and eyes over decades.

When to seek medical advice

If you have symptoms such as unexplained thirst, passing urine frequently, unintended weight loss, recurrent infections or blurred vision, see your GP — these warrant testing. If you already have diabetes and develop vomiting, drowsiness, rapid breathing or confusion, seek urgent medical help. And never change or stop diabetes medication without discussing it with your own clinical team.

A closing thought

The most damaging thing about the folk version of type 2 diabetes is the shame built into it. The real version — genes, biology, fat in the wrong organs, an environment engineered against us — leaves room for something more useful than shame: understanding, and in many cases, genuine room to act.

Further reading and sources

• NICE NG28 — Type 2 diabetes in adults: management
• Diabetes UK — information on type 2 diabetes and remission
• The DiRECT trial (Diabetes Remission Clinical Trial) — primary results and follow-up reports
• American Diabetes Association — Standards of Care in Diabetes
• NHS — type 2 diabetes overview

Brand names are mentioned for identification only. The author has no commercial relationship with any manufacturer, and nothing here is an advertisement for, or recommendation to obtain, any medicine.